Zobrazeno 1 - 10
of 256
pro vyhledávání: '"Alvarez-Calderon F"'
Autor:
Rui X; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., Alvarez Calderon F; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., Wobma H; Harvard Medical School, Boston, MA 02115, USA.; Division of Immunology, Boston Children's Hospital, Boston, MA 02215, USA., Gerdemann U; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., Albanese A; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., Cagnin L; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., McGuckin C; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., Michaelis KA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., Naqvi K; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.; University of British Columbia, Vancouver, BC V6T 1Z1, Canada., Blazar BR; Division of Pediatric Blood and Marrow Transplant and Cellular Therapy, University of Minnesota, Minneapolis, MN 55455, USA., Tkachev V; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.; Harvard Medical School, Boston, MA 02115, USA.; Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA 02129, USA., Kean LS; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Oct 16; Vol. 16 (769), pp. eadj9331. Date of Electronic Publication: 2024 Oct 16.
Autor:
Bourgeois W; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Paolino J; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Garland R; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Campbell K; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Alvarez-Calderon F; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Frazier AL; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., O'Neill AF; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Ilowite M; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Wong CI; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass.; Division of Pediatric Hematology-Oncology, University Hospitals Rainbow Babies and Children's Hospital, Cleveland, Ohio.; Division of Hematology-Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Publikováno v:
Pediatric quality & safety [Pediatr Qual Saf] 2024 Sep 25; Vol. 9 (5), pp. e771. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Autor:
Kaminski J; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Fleming RA; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA., Alvarez-Calderon F; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Winschel MB; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA., McGuckin C; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA., Ho EE; 2seventy bio, Cambridge, MA., Eng F; 2seventy bio, Cambridge, MA., Rui X; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA., Keskula P; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA., Cagnin L; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA., Charles J; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA., Zavistaski J; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA., Margossian SP; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Kapadia MA; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Rottman JB; 2seventy bio, Cambridge, MA., Lane J; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA., Baumeister SHC; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Tkachev V; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA., Shalek AK; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA.; Ragon Institute of Massachusetts General Hospital, MIT and Harvard, Cambridge, MA., Kean LS; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Gerdemann U; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
Blood [Blood] 2024 Jul 04; Vol. 144 (1), pp. 46-60.
Autor:
Saha A; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Palchaudhuri R; Magenta Therapeutics, Cambridge, MA., Lanieri L; Magenta Therapeutics, Cambridge, MA., Hyzy S; Magenta Therapeutics, Cambridge, MA., Riddle MJ; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Panthera J; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Eide CR; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Tolar J; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Panoskaltsis-Mortari A; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Gorfinkel L; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA., Tkachev V; Massachusetts General Hospital Center for Transplantation Sciences, Mass General Brigham and Massachusetts General Hospital, Boston, MA., Gerdemann U; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA., Alvarez-Calderon F; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA., Palato ER; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA., MacMillan ML; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Wagner JE; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Kean LS; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA., Osborn MJ; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Kiem HP; Department of Medicine, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA., Scadden DT; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Stem Cell Institute, Cambridge, MA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA., Olson LM; Magenta Therapeutics, Cambridge, MA., Blazar BR; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
Publikováno v:
Blood [Blood] 2024 May 23; Vol. 143 (21), pp. 2201-2216.
Autor:
Alvarez Calderon F; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Harvard Medical School, Boston, MA., Kang BH; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Cambridge, MA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA., Kyrysyuk O; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Zheng S; Department of Genetics and Genomic Sciences, Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY., Wang H; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Immunology, Harvard Medical School, Boston, MA., Mathewson ND; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Immunology, Harvard Medical School, Boston, MA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA., Luoma AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Immunology, Harvard Medical School, Boston, MA., Ning X; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Immunology, Harvard Medical School, Boston, MA., Pyrdol J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Cao X; Department of Genetics and Genomic Sciences, Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY., Suvà ML; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA., Yuan GC; Department of Genetics and Genomic Sciences, Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY., Wittrup KD; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Cambridge, MA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Immunology, Harvard Medical School, Boston, MA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA.
Publikováno v:
Blood [Blood] 2024 Mar 21; Vol. 143 (12), pp. 1124-1138.
Autor:
Wobma H; Division of Immunology, Boston Children's Hospital, Boston, MA., Kapadia M; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Alvarez-Calderon F; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Baumeister SHC; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Duncan C; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Forrest S; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Gorfinkel L; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Huang J; Division of Immunology, Boston Children's Hospital, Boston, MA., Lehmann LE; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Li H; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Schwartz M; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Koreth J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA., Ritz J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA., Kean LS; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Whangbo JS; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2023 Aug 22; Vol. 7 (16), pp. 4647-4657.
Autor:
Gerdemann U; Dana-Farber Cancer Institute., Alvarez-Calderon F; Dana-Farber Cancer Institute.
Publikováno v:
Blood [Blood] 2022 Jul 28; Vol. 140 (4), pp. 294-296.
Autor:
Nguyen, Joe T.1,2 (AUTHOR) joe.nguyen@nih.gov, Jessri, Maryam3,4 (AUTHOR) maryam.jessri@health.qld.gov.au, Costa-da-Silva, Ana C.2 (AUTHOR) rubina.sharma@nih.gov, Sharma, Rubina2 (AUTHOR) jacqueline.mays@nih.gov, Mays, Jacqueline W.2 (AUTHOR), Treister, Nathaniel S.5,6 (AUTHOR) joe.nguyen@nih.gov
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10411. 19p.
Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme.
Autor:
Cooksey, Luke C.1,2 (AUTHOR) lukecooksey@my.unthsc.edu, Friesen, Derek C.1 (AUTHOR) derekfriesen@my.unthsc.edu, Mangan, Enrique D.1 (AUTHOR) enriquemangan@my.unthsc.edu, Mathew, Porunelloor A.1,2 (AUTHOR) porunelloor.mathew@unthsc.edu
Publikováno v:
Cells (2073-4409). Sep2024, Vol. 13 Issue 18, p1567. 16p.
Autor:
Byrne, Catherine M1 (AUTHOR), Márquez, Ana Citlali2 (AUTHOR), Cai, Bing3 (AUTHOR), Coombs, Daniel4 (AUTHOR), Gantt, Soren5 (AUTHOR) soren.gantt@umontreal.ca
Publikováno v:
PLoS Computational Biology. 8/16/2024, Vol. 20 Issue 8, p1-21. 21p.